Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 30, 2021

SELL
$251.87 - $278.14 $1.67 Million - $1.84 Million
-6,625 Closed
0 $0
Q4 2020

Jan 29, 2021

SELL
$186.91 - $214.42 $8.87 Million - $10.2 Million
-47,464 Reduced 87.75%
6,625 $1.35 Million
Q3 2020

Oct 30, 2020

SELL
$167.03 - $201.3 $207,117 - $249,612
-1,240 Reduced 2.24%
54,089 $10.2 Million
Q2 2020

Aug 03, 2020

SELL
$113.31 - $182.44 $6.84 Million - $11 Million
-60,335 Reduced 52.16%
55,329 $9.19 Million
Q1 2020

Apr 30, 2020

BUY
$104.32 - $195.28 $9.47 Million - $17.7 Million
90,784 Added 364.89%
115,664 $14.6 Million
Q4 2019

Jan 31, 2020

SELL
$163.48 - $173.61 $177,375 - $188,366
-1,085 Reduced 4.18%
24,880 $4.21 Million
Q3 2019

Nov 04, 2019

SELL
$159.77 - $178.1 $200,511 - $223,515
-1,255 Reduced 4.61%
25,965 $4.36 Million
Q2 2019

Jul 31, 2019

BUY
$144.16 - $172.9 $3.92 Million - $4.71 Million
27,220 New
27,220 $4.71 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.6B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Kornitzer Capital Management Inc Portfolio

Follow Kornitzer Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Kornitzer Capital Management Inc with notifications on news.